Screener

Stock-based compensation expense

Name: BioCryst Pharmaceuticals Stock-based compensation expense by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BioCryst Pharmaceuticals·Business Segments·1 segment·Rolls up to Compensation and benefits

Breakdown

Segment	Q1 '26	Q2 '26
Business Segments	$16.03M	$14.69M
Total	$16.03M	$14.69M

Segments

Business SegmentsView metric